BACKGROUND. Some children who present with fever and erythroderma have rapid clinical deterioration or progress to toxic shock syndrome. Our primary objective was to determine whether specific clinical features of those who present with fever and erythroderma can predict who will develop hypotension or progress to toxic shock syndrome. Our secondary objective was to describe the clinical presentation, course, and outcome of children with fever and erythroderma.
RYTHRODERMA IS AN uncommon finding among febrile patients and may be a manifestation of a variety of illnesses, including infections, toxin-mediated disease, and drug-related reactions. The evaluation of fever in children has been well studied, but patients with fever and erythroderma are a special circumstance and challenge for the clinician. Some children who present with fever and erythroderma have rapid clinical deterioration or progress to toxic shock syndrome (TSS). At presentation, it is difficult to determine which patients will develop shock. No previous studies have investigated whether historical examination, physical examination, or laboratory findings can help predict clinical deterioration or the progression to TSS. The Centers for Disease Control and Prevention (CDC) definitions for staphylococcal and streptococcal TSS are listed in Tables 1 and 2 . 1 Our primary objective was to determine whether specific clinical features of those who present with fever and erythroderma can predict who will develop hypotension, clinical shock, or TSS. On the basis of the literature and anecdotal experience, we hypothesized that patients who present with severe gastrointestinal complaints, ill appearance, or mucous membrane hyperemia are more likely to develop clinical deterioration or progress to TSS. In addition, we suspect that patients with acidosis, electrolyte abnormalities, or thrombocytopenia are also more likely to clinically deteriorate. Our secondary objective was to describe the clinical presentation, course, and outcome of children with fever and erythroderma.
METHODS

Study Design/Patients
We conducted a retrospective medical chart review of children Յ19 years of age with fever and erythroderma who presented to an urban pediatric emergency department (ED) between January 2001 and December 2005. Potential cases were identified through an electronic text search tool; physician medical charts of the ED visit were searched for the specific words or phrases. The text search methodology allows for wild-card characters and "fuzzy" logic to identify words or parts of words near other terms. The following terms were searched with variations using wild cards and logical statements: erythroderma, diffuse erythema, confluent erythema, toxic and shock (or hypotension), toxin and shock (or hypotension), staphylococcal and shock (or hypotension), and streptococcal and shock (or hypotension). As an example of the search strategy, a search for "eryth%" and "shock" (or "hypotens%") would identify all of the charts with the words erythematous, erythema, erythroderma, erythrocytes, and erythromycin, as well as the word shock, hypotension, or hypotensive (even if the chart reads "no signs of shock" or "never hypotensive"). Patients were included if they met the following criteria: fever of 38°C by history or triage temperature and erythroderma defined as a diffuse skin erythema or "sunburnlike erythema" that was not evanescent or patchy. Rashes that were described as scarlatiniform, "sandpaper," maculopapular, or not diffuse (limited to 1 body part or region) were not considered an erythroderma for study purposes. Patients were further excluded if they were immunocompromised or were transferred to the ED from an inpatient unit at another facility. All of the cases were reviewed by both authors for entry into study.
Data Collection: ED Visit
Historical, clinical, and laboratory data were abstracted from the medical chart and entered into a database form with data validation rules. Historical data included the following: date of birth, date of visit, gender, 14 presenting symptoms (fever, measured temperature, headache, dizziness, altered mental status, sore throat, neck stiffness, myalgias, chest pain, abdominal pain, vomiting, diarrhea, gastrointestinal bleeding, and decreased urine For study purposes, specific a priori definitions were developed for examination elements: general appearance was coded as "well" (as defined by a record with terms such as: "well appearing," "alert," "happy," "nonill appearing," "playful," and "interactive"), "not well" (defined as "fussy," "lethargic," "sleepy but arousable," "irritable," "ill, but non toxic," "sick," and "uncomfortable"), and "toxic" (defined as "limp," "cyanotic," "mottled," "moribund," "toxic," "septic," "poorly perfused," "apneic," "gray," and "severe distress"); the most severe category was chosen if terms from multiple categories existed. Mental status was coded as "normal" (defined by terms such as "alert," "interactive," and "appropriate"), "lethargic" ("difficult to arouse," "poor tone," and "somnolent"), or obtunded ("decreased responsiveness," "unresponsive," "confused," and "inappropriate"). Signs of focal infections (abscess, adenitis, pharyngitis, pneumonia, purulent vaginal or cervical discharge, tracheitis, cellulitis, septic arthritis, osteomyelitis, and urinary tract infection/pyelonephritis) were also abstracted from the record.
Historical elements were coded as present, absent, or missing (if not recorded) on the basis of the medical chart. Physical examination findings were also coded as present or absent; when a sign was not mentioned, the finding was coded as absent.
Laboratory results from the ED evaluation were collected and studied if collected within 2 hours of the initial evaluation and before therapy with fluids. Chemistries, results of complete blood count, liver function tests, coagulation studies, inflammatory markers (erythrocyte sedimentation rate and C-reactive protein), urinalysis (collected within 8 hours from triage), and any body fluid analysis (cerebrospinal fluid, joint fluid, and pleural fluid) were recorded.
Data Collection: Clinical Management and Follow-up
The ED record and the inpatient medical chart (when admitted) were reviewed for therapeutic interventions and course. Clinical data included: length of stay, length of ICU stay, development of hypotension (Յ5th percentile systolic arterial pressure for age), 2 fluid resuscitation (requirement of Ն60 mL/kg of crystalloid within a 6-hour period), administration and duration of vasopressors, antibiotic use, and any laboratory data including results of bacterial cultures or serologies. Antibiotics that were considered to be "antistaphylococcal" included cephalosporins (first generation), clindamycin, dicloxacillin, nafcillin, oxacillin, and vancomycin. The medical chart was also reviewed for any outpatient follow-up visits at the hospital related to the index encounter, any morbidity as defined by decrease in neurologic function or other prolonged organ dysfunction, and survival.
Outcome Measures
Major outcomes included (1) the development of hypotension defined as either a systolic blood pressure Յ90 mm Hg if Ն16 years of age or a systolic blood pressure Յ5th percentile if Ͻ16 years of age, 2 (2) the administration of vasopressors, (3) the development of shock defined as either the administration of isotonic fluid boluses or colloid Ն60 mL/kg within a 6-hour period or hypotension (described as above), and (4) the development of CDC-defined staphylococcal or streptococcal TSS (confirmed or probable). 1 The CDC definitions for TSS are listed in Tables 1 and 2 .
Analysis
For patients who were not hypotensive on arrival to the ED, we analyzed historical examination, physical exam- a. Renal impairment: creatinine Ն2 mg/dL (Ն177 mol/L) for adults or more than or equal to twice the upper limit of normal for age. In patients with preexisting renal disease, a more than twofold elevation over the baseline level. b. Coagulopathy: platelets Յ100 000/l or disseminated intravascular coagulation, defined by prolonged clotting times, low fibrinogen level, and the presence of fibrin degradation products c. Liver involvement: ALT, aspartate aminotransferase, or total bilirubin levels more than or equal to twice the upper limit of normal for the patient's age. In patients with preexisting liver disease, a more than twofold increase over the baseline level d. Acute respiratory distress syndrome: defined by acute onset of diffuse pulmonary infiltrates and hypoxemia in the absence of cardiac failure or by evidence of diffuse capillary leak manifested by acute onset of generalized edema or pleural or peritoneal effusions with hypoalbuminemia e. A generalized erythematous macular rash that may desquamate f. Soft-tissue necrosis, including necrotizing fasciitis, myositis, or gangrene 3. Laboratory criteria for diagnosis: isolation of group A streptococcus Confirmed streptococcal TSS: a case that meets the clinical case definition with isolation of group A streptococcus from a normally sterile site (eg, blood or cerebrospinal fluid, joint, or pleural or pericardial fluid) Probable streptococcal TSS: a case that meets the clinical case definition with isolation of group A streptococcus from a nonsterile site (eg, pharynx)
Source of CDC definition is ref 1. ination, and laboratory parameters as potential predictors for development of hypotension, shock, and shock requiring vasopressors. For all of the patients, including those hypotensive on arrival, we evaluated clinical data for predicting the development of staphylococcal or streptococcal TSS. Historical data elements with Ͼ20% missing data were not analyzed. A dichotomous variable for elevated creatinine was classified by age-based ranges. 3 Statistical analysis was performed using SPSS 14.0 (SPSS Inc, Chicago, IL). 2 analysis was used to compare categorical data, and independent samples t tests were used to compare mean values of continuous variables (normally distributed data). Mann Whitney U test was used to compare nonparametric data. A P value of Յ.05 was considered statistically significant. Odds ratios with 95% confidence intervals (CIs) were calculated for categorical comparison, and mean differences with 95% CIs were calculated for continuous variable comparison. CIs for proportions and likelihood ratios were calculated with Stata 6 (Stata Corp, College Station, TX).
Recursive partitioning analysis (CART 5, Salford Systems, Palo Alto, CA) was used for determining the best cutpoint for continuous variables and to develop a multivariate prediction model for both the development of hypotension and the development of TSS. Recursive partitioning analysis develops a classification tree where a parent node is divided into child nodes using available candidate predictors. At each decision point, the variable that best divides the parent node toward homogenous nodes (on the basis of binary outcome variable) is used. At the end of the analysis, all of the patients are divided into "high-risk" and "low-risk" child nodes for the outcome variable. We entered our a priori predictors (gastrointestinal symptoms, ill appearance, mucosal hyperemia, acidosis, and thrombocytopenia), as well as any predictors with P ϭ .2 on univariate analysis. A "penalty" was assigned to variables for missing data such that the program preferentially uses variables with complete data. In addition, we adjusted the "cost" of misclassification; a misclassification of a patient that eventually became hypotensive into a "low-risk" (for hypotension) group was considered 50 times worse that misclassifying a patient as "high-risk" for hypotension when in fact they never became hypotensive. Cost of misclassification was not adjusted for development of TSS. The study was approved by the institutional review board, and data collection was compliant with the Health Insurance Portability and Accountability Act of 1996.
RESULTS
Study Population
A total of 518 cases were identified by the text search strategies. All of the charts were reviewed as potential study patients. Sixty patients had fever and erythroderma by case definitions. Of the final 60 cases, 54 (90%) were identified by Ն2 search strategies. Four patients with fever and erythroderma were excluded: 2 patients were immunocompromised (both oncologic diagnoses), 1 patient had a prolonged inpatient admission before the ED visit, and 1 patient had incomplete documentation of the ED visit. The balance of 56 cases was studied. We estimated the frequency of fever and erythroderma to be ϳ0.024% per year (60 cases of 256 606 visits in 5 years) or 1 patient per 4000 visits in our academic pediatric ED.
The median age of the study patients was 10.7 years (interquartile range [IQR]: 2.8 -14.8 years) with 50% of the patients being male. Forty-six patients presented normotensive, and 10 patients (18%) were hypotensive on arrival. Table 3 shows the presenting symptoms and signs of patients with fever and erythroderma. Fortyeight percent of patients presented with vomiting, and 42% of patients presented with duration of fever Ͻ24 hours. Forty-three percent of patients reported using a new medication (diphenhydramine, hydroxyzine, promethazine, cough suppressant, and oral antibiotics) during the 14 days before presentation, and 11% reported use of a medication chronically. Three patients presented after a surgical procedure (5 days status post [s/p] incision and drainage of pilonidal cyst, 8 days s/p herniorrhaphy and orchiopexy, and 5 days s/p circumcision). Thirty-two percent (9 of 28) of the female patients presented with active menstruation, and 8 of 9 were currently using tampons.
The mean triage temperature was 38.4°C (SD: 0.8°C), and 30% of patients presented with temperature Ն39°C. On physical examination, 45% of patients were described as ill appearing, and all of the patients had a normal mental status. Twenty-one percent of patients presented with conjunctivitis, and 29% had oropharyngeal hyperemia. Fourteen percent of patients had petechiae in addition to erythroderma. Fifty-two percent of patients had an identifiable focal source of infection including cellulitis without abscess (15) , abscess (9), group A streptococcal pharyngitis (2), adenitis (1), osteomyelitis (1), and pneumonia (1) .
In comparing those who were not hypotensive on arrival with those hypotensive on arrival, mean age and ill appearance were less for the patients not hypotensive on arrival (8.4 vs 13.7 years [P ϭ .008] and 35% vs 89% [P ϭ .007], respectively). There was no significant difference in mean temperatures, heart rates, and respiratory rates. In addition, there was no significant difference in physical examination findings, such as mental status, mucosal hyperemia, petechiae, or focal bacterial infections. The initial laboratory findings of study patients are listed in Table 4 . Overall there was not a significant difference in laboratory values for those with and without hypotension on arrival except for the mean number of polymorphonuclear neutrophils (P ϭ .046) and proportion of patients with elevated creatinine (P ϭ .024).
Clinical Course
The clinical course for the patients studied is summarized in Fig 1. On initial evaluation, 10 (18%) of 56 patients presented with documented hypotension. Thirteen (28%) of the remaining 46 patients who were normotensive on arrival developed hypotension. An additional 2 patients were treated with aggressive fluid resuscitation (Ն60 mL/kg over a 6-hour period) for a total of 15 (33%) of 46 who developed clinical shock. The median time between presentation and hypotension was 8 hours (IQR: 2.8 -12.5 hours). Of the 23 patients who were hypotensive at any point during their hospitalization, 12 (52%) required vasopressor support. The median length of vasopressor infusion was 15 hours (IQR: 9 -63 hours). As mentioned previously, 13 (28%) of 46 patients who were normotensive on arrival developed hypotension, and 7 of these patients required vasopressors. Fifty-one (91%) of 56 patients were hospitalized with the median length of hospitalization 64 hours (IQR: 48 -104 hours), and 18 (32%) of 56 required ICU admission from the ED or inpatient unit with the median length of ICU stay 43 hours (IQR: 18 -94 hours). Of the 18 patients who required ICU admission, 8 were hypotensive on arrival (to the ED), and 10 developed hypotension after their initial evaluation. None of the study patients required intubation.
The 5 patients who were discharged from the ED had discharge diagnoses of abscess, viral pharyngitis, viral syndrome, staphylococcal scalded skin syndrome, and serum sickness. The patient who was discharged with the diagnosis of serum sickness returned to the ED the next day with fluid-responsive shock; final diagnosis for this patient was serum sickness or viral sepsis. One patient was noted to have follow-up in the medical chart with no mention of subsequent illness, and 3 patients had no follow-up recorded in the medical chart. Only 1 of the 56 patients suffered significant morbidity (loss of tissue with grafting secondary to tissue necrosis), and there were no deaths reported.
Predictors
Development of Hypotension After Arrival
The clinical characteristics of patients who remained normotensive and those who developed hypotension after arrival to the ED are compared in Table 5 . Patients were more likely to develop hypotension if they were older (P ϭ .017), presented with vomiting (P ϭ .015), or were ill appearing (P ϭ .036). In addition, those patients who developed hypotension were more likely to have hematuria (red blood cells in the urine; P ϭ .045), higher mean blood (serum) urea nitrogen (BUN; P ϭ .01), higher mean glucose (P ϭ .015), higher percentage of peripheral neutrophils (P ϭ .003), elevated creatinine (P ϭ .042), and a lower mean calcium (P ϭ .034).
Development of Hypotension Requiring Vasopressor Therapy
Compared with patients who remained normotensive or had fluid-responsive shock, patients who developed hypotension requiring vasopressor support had higher mean ages (years: 13. 
Recursive Partitioning Analysis
Thirteen variables were entered as potential predictors on the basis of a priori hypotheses and results of univariate analysis. Nine variables were determined to be the most important predictors of developing hypotension in patients initially normotensive: age Ն3 years, ill appearance, vomiting, glucose Ն110 mg/dL, calcium Յ8.6 mg/ dL, platelets Յ300 000/uL, elevated creatinine, polymorphonuclear leukocytes (PMNs) Ն80%, and presence of a focal infection. Table 6 shows these variables with associated positive and negative likelihood ratios and with cut points for continuous variables. In all of the patients studied, 4 variables were determined to be the most important predictors of developing TSS: age Ն3 years, ill appearance, elevated creatinine, and hypotension on arrival. Decision trees were created using recursive partitioning for the development of hypotension and development of TSS. The models and their prediction success are shown in Figs 2 and 3. Positive and negative likelihood ratios (LR ϩ and LR Ϫ ) are provided for each outcome (N ϭ 46). a Variable importance: this is a relative score provided by recursive partitioning analysis. Variables that contribute most in classifying or predicting the target variable have the highest score (relative to best predictor with score of 100); contribution includes role as a primary splitter (parent nodes) and as a surrogate of any primary splitters. b Age-based ranges. 3
Final Diagnoses
Twenty-nine patients (52%) had a focal source of infection on presentation. Twenty-nine patients (52%) had a positive bacterial culture (from any site cultured) for Staphylococcus aureus (18) , Streptococcus pyogenes (8), or both (3). Three of these patients had bacteremia (1 had
FIGURE 2
Recursive partitioning model for development of hypotension after arrival.
FIGURE 3
Recursive partitioning model for predicting TSS. a Agebased ranges. 3 S aureus and 2 had S pyogenes). Ninety-three percent (52 of 56) of all cases were given an antibiotic. Of the 52 patients, 50 patients were treated with intravenous antibiotics, 1 patient was started on an oral antibiotic, and a single patient was given a dose of an intravenous antibiotic to be followed with a course of oral antibiotics. The single patient who was initially discharged from the hospital and returned in clinical shock was not started on antibiotics until the second visit. Eighty-seven percent (45 of 52) were given an "antistaphylococcal" antibiotic, and 71% (37 of 52) were given clindamycin either alone or in combination with another antibiotic. Sixteen patients (29%) met the CDC definition for either staphylococcal or streptococcal TSS (confirmed or probable); the frequency of CDC-defined TSS was 0.0064% (16 cases of 256 606 visits over 5 years). However, many patients were considered to have possible toxin-mediated disease or possible TSS as their final diagnosis. One patients did not meet CDC-defined TSS because of a maximum temperature Ͻ38.9°C; 2 patients did not meet CDC-defined TSS because they had only 2 of 3 organ systems involved; and 2 patients never had a recorded systolic blood pressure below the 5th percentile despite having clinical shock. Only 2 bacterial isolates were sent for detection of toxin production; the only positive test for TSS toxin occurred in a patient with fever, erythroderma, and hypotension who never met CDC definition of TSS secondary to lack of multisystem organ involvement. Serum samples from 5 patients were sent for toxin antibody, and all of the samples were reported as negative. Among patients with fever and erythroderma who did not have a focal bacterial infection or progression to TSS, other final diagnoses included: drug hypersensitivity (2 patients), staphylococcal scalded skin syndrome, serum sickness, viral syndrome, superinfected eczema, and superinfected varicella.
DISCUSSION
Review of the Literature
A wide array of illnesses, from benign to life threatening, present with fever and rash. The workup of a child with fever and rash often depends on the quality of the rash and the toxicity of the child. Erythroderma without fever can be seen in a variety of dermatologic conditions, including psoriasis, ichthyosis, atopic dermatitis, sarcoidosis, and Sé zary syndrome. 4 The combination of fever and erythroderma is particularly concerning given the potential for life-threatening illness. The differential diagnosis includes a variety of illnesses, such as bacterial infections, viral infections, Kawasaki disease, drug-related reactions, and toxin-mediated disease, including TSS.
TSS was first named by Todd et al 5 in 1978. They described a series of pediatric cases of high fever, ill appearance, headache, conjunctival hyperemia, confusion, poor perfusion, and rash that were associated with vomiting, diarrhea, decreased urine output, hepatic abnormalities, renal abnormalities, shock, and a staphylococcal toxin.
The incidence of TSS greatly increased in 1979 and 1980 in young healthy women. 6 This increase led to many retrospective case-control studies that described an association between TSS and prolonged tampon use during menstruation. [6] [7] [8] [9] [10] [11] [12] Many recommendations were made on the basis of the literature, and an aggressive media campaign ensued leading to a decrease in menstrual TSS cases. 13 Nonmenstrual TSS can be seen in a wide variety of clinical scenarios, including focal lesions of soft tissue, bone infections, and lung infections. Cases have been reported in burn victims and after specific infections, such as influenza and varicella. [14] [15] [16] Other cases have been reported to be postsurgical, postpartum, and postabortion. 13 In 1980, the first CDC case definition for TSS was published. 9 The case definition has since been revised, and a separate case definition of streptococcal TSS exists. 1, 16, 17 Although there are strict CDC definitions for TSS, the clinical presentation, laboratory abnormalities, and course of illness have been noted to be highly variable. 18 Medical literature on TSS in children is limited. According to the 17-year (1979 -1996) CDC surveillance update, 50 cases of TSS were reported in children Ͻ5 years of age with more than half of the cases occurring in children Ͻ2 years of age. Of the 50 cases, 61.7% were associated with a nonsurgical skin lesion, and the overall case/fatality ratio was 4%. 13 Wiesenthal and Todd 19 described the clinical and laboratory findings of 7 children (4 boys and 3 girls) Ͻ10 years of age with CDC-defined TSS during the period of March 1977 to August 1981. All of the patients had fever, erythroderma, and mucous membrane hyperemia on admission. Four patients were hypotensive on admission, and 3 developed hypotension during the hospital course. One patient died from shock, another patient developed extensive tissue necrosis requiring grafting, and finally 1 patient met the definition for Kawasaki disease and developed left-sided heart failure, coronary aneurysms, and pulmonary edema. The 3 girls appeared to have a milder illness than the boys, and S aureus grew from cultures of 4 patients. They concluded that the clinical and laboratory findings (electrolyte, renal, and hepatocellular) were similar to adult patients; however, the pediatric cases had more pulmonary dysfunction. 19 Other descriptive case reports of children with TSS have included small numbers of patients. [20] [21] [22] In 2000, Laupland et al 14 conducted a population-based prospective surveillance study describing children with invasive group A streptococcus disease. They reported that 7% of children with invasive group A streptococcal disease developed streptococcal TSS. The case fatality rate for streptococcal TSS was 56%. In 2005, Chiang et al 21 reported 4 cases of streptococcal TSS in children without skin and soft tissue infections; pharyngitis was identified in 3 of their 4 cases.
Summary of Findings
In our population, we found that 28% of patients who presented with fever and erythroderma developed hypotension after arrival to the ED. Overall, 45% of patients with fever and erythroderma developed shock, including 33% of those who were normotensive on presentation. Of those who developed hypotension, Ͼ50% of patients required vasopressors. Despite the development of hypotension, use of vasopressors, and requirement of critical care, long-term morbidity was uncommon. Fifty-two percent of patients with fever and erythroderma had a focal source of infection at presentation and, of those, half of the patients had a positive bacterial culture. Only 5% of the patients had bacteremia despite the large number of patients with sepsis physiology consistent with the role of toxin and inflammatory mediators rather than overwhelming bacterial infection.
Patients who were older and who presented with vomiting, ill appearance, elevated BUN, elevated creatinine, elevated glucose, decreased calcium, elevated percentage of polymorphonuclear leukocytes, and hematuria were more likely to develop hypotension after arrival. Exploratory analysis with recursive partitioning identified 9 variables as the most important predictors of developing hypotension: age Ն3 years, ill appearance, vomiting, glucose Ն110 mg/dL, calcium Յ8.6 mg/dL, platelets Յ300 000/L, elevated creatinine, PMNs Ն80%, and presence of a focal infection.
Only 29% of patients met the CDC definition for either staphylococcal or streptococcal TSS. Patients who were older and who presented with ill appearance, elevated BUN, elevated creatinine, elevated ALT, and decreased calcium were more likely to develop TSS. Recursive partitioning identified 4 variables as the most important predictors of developing TSS: age Ն3 years, ill appearance, elevated creatinine, and hypotension on arrival. The relatively low percentage of patients who met the CDC definition likely reflects a wider spectrum of disease not captured by the restrictive nature of the CDC definition. It is possible that the CDC definition for TSS may be conservative for clinical purposes.
Limitations
The most significant limitation is the retrospective design that limits the ability to abstract accurate, complete clinical information from the medical chart. In addition, we may have incomplete case identification through our text search tool; case identification was redundant for the various search strategies and, therefore, should have minimized the number of missing patients. Clinical findings, such as general appearance and mental status, are often subjective and difficult to determine retrospectively even in well-documented charts. We used a priori definitions to assist in abstracting data of this type; however, limitations in accuracy exist. We attempted to capture those patients with true erythroderma by using strict criteria; however, we relied on appropriate documentation to make the determination. Historical elements not documented in the medical chart were considered to be missing, whereas physical examination findings not documented were presumed to be negative; the decision was felt to be best for a retrospective review but carries the biases of inaccurate and incomplete documentation. We also studied management of these patients that is not based on any specific guideline or standard of care; for instance, the use of vasopressors was studied and felt to be objectively recorded, but the threshold to use or discontinue vasopressors is not universal among physicians. Our outcomes are also not entirely complete with regard to long-term follow-up on patients. Three of the 5 patients discharged from the ED initially did not have long-term follow-up.
Although performing repeated univariate analyses, our results are subject to a type I statistical error; an adjusted level of significance could have been used, but with such a small study population, we retained a significance for P Յ .05 to broadly identify potential predictors for hypotension and TSS. Although this is the first study of children with fever and erythroderma that attempts to predict outcome, the sample size limits the conclusions about predictive strength of any of the clinical variables. Using a relatively small number of patients to build a multivariate model, recursive partitioning likely "overfit" the data, especially with adjusted cost of misclassification. Thus, our models should be viewed as exploratory analysis with the need for larger derivation sets and, ideally, prospective study.
CONCLUSIONS
The presentation of fever and erythroderma is uncommon, accounting for 1 in 4000 visits to an academic pediatric ED. Despite being an infrequent presentation, early recognition is essential. Overall, 45% of patients with fever and erythroderma developed shock, including 33% of those who were normotensive on presentation. Despite the development of hypotension, use of vasopressors, and need for critical care, long-term morbidity is uncommon. Older age, presence of vomiting, identification of a focal bacterial source, as well as specific laboratory parameters can be used to help predict which patients are likely to have hemodynamic deterioration. Given the high rate of clinical decompensation, all patients with fever and erythroderma should be admitted, closely monitored, and managed aggressively.
